Disease Info Card

Hereditary Pyropoikilocytosis

Information about Hereditary Pyropoikilocytosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hereditary Pyropoikilocytosis

Most recent studies have shown that Hereditary Pyropoikilocytosis shares some biological mechanisms with anemia, anemia-hemolytic, anemia-hemolytic-congenital, carcinoma, diabetes-mellitus, elliptocytosis-hereditary, familial-periodic-paralysis, hemolysis-(disorder), hereditary-spherocytosis, hyperkalemic-periodic-paralysis, hyperplasia, hypertensive-disease, hypoglycemia, hypokalemic-periodic-paralysis, hypophosphatasia, malignant-neoplasms, neoplasms, pancreatic-neoplasm, periodic-paralysis-(finding), weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hereditary Pyropoikilocytosis, and have been seen in publications frequently: Angiogenesis, Bone Mineralization, Cell Proliferation, Excretion, Fermentation, Gastric Emptying, Germination, Glomerular Filtration, Glucagon Secretion, Hormone Secretion, Insulin Secretion, Ion Transport, Lipid Oxidation, Localization, Pancreatic Polypeptide Secretion, Pathogenesis, Protein Denaturation, Reflex, Secretion, Transport

Quite a number of genes have been found to play important roles in Hereditary Pyropoikilocytosis, such as ALPL, CCK, DLC1, GAST, GCG, HP, IL3, INS, NPY, PPA1, PPY, PSMB8, PYY, RIPK2, SPTA1, SST, TAP2, TFF2, VIP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.